Ativo Capital Management’s Medifast MED Stock Holding History

Ativo Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,400	Closed	-$1.42M	–	156
2018 Q3	$1.42M	Sell	6,400 -1,202	-16%	-$244K	0.38%	87
2018 Q2	$1.22M	Sell	7,602 -8,403	-53%	-$1.07M	0.34%	111
2018 Q1	$1.5M	Sell	16,005 -3,001	-16%	-$224K	0.42%	64
2017 Q4	$1.33M	Sell	19,006 -6,001	-24%	-$398K	0.35%	112
2017 Q3	$1.49M	Sell	25,007 -6,001	-19%	-$299K	0.4%	88
2017 Q2	$1.29M	Hold	31,008	–	–	0.35%	114
2017 Q1	$1.38M	Hold	31,008	–	–	0.34%	104
2016 Q4	$1.29M	Hold	31,008	–	–	0.3%	110
2016 Q3	$1.17M	Buy	31,008 +12,208	+65%	+$438K	0.27%	121
2016 Q2	$625K	Buy	+18,800	New	+$607K	0.15%	202

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ativo Capital Management's MED Position: Q4 2018 in Review

Ativo Capital Management sold out of Medifast (MED) in Q4 2018, closing a stake of 6,400 shares — an estimated $1.42M sold.

Ativo Capital Management first reported a position in MED in Q2 2016 and held it in 10 quarters. The position peaked at $1.5M in Q1 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

Ativo Capital Management reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
Ativo Capital Management sold 6,400 Medifast shares in Q4 2018, an estimated $1.42M.
Ativo Capital Management first reported a position in Medifast in Q2 2016 and held it in 10 quarters.
Ativo Capital Management's Medifast position peaked at $1.5M in Q1 2018.
247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Ativo Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.